All Type of News
‘Double torture’ on pharma industry
It was concerned the pharmaceutical industry is encountering a double torture, enforcement of the Kim Young-Ran Law and entry restriction from medical institutes.
According to the pharmaceutical industry, pharmaceuti...
“Zuellig have strong points, such as customer confidence, logistics system and service”Zuellig Pharma showed confidence over the pharmaceutical distribution competition in the Korean market.
At a meeting with Yakup Shinmoon, Zuellig Pharma Korea CEO Christophe Pi...
|
Pharmaceutical association’s anger against KMA’s discussion over 6-year curriculum
In response to the Korean Medical Association’s(KMA) announcement that it is improper to discuss the reorganization of the current pharmacy university curriculum to an integrated 6-year system, the Korean Pharmaceutic...
KPA, “It’s improper to discuss reorganization of pharmacy university curriculum”
When it comes to the academic circles’ argument that the pharmacy college system should be changed to a 6-year system, the Korean Medical Association(President Moo-Jin Choo, KMA) expressed an opinion “Since it is impr...
“Supports for pharmaceutical industry will continue in 2017”
In order to secure competitiveness, the government will continue the supporting plan for the Korean pharmaceutical industry next year once again.
At the ‘2017 KHIDI Health Industry Prospect’ on the 14th, Ji-Young Yoo...
SK Chemicals & Lilly Korea sign co-marketing agreement of Cymbalta
On the 15th, SK Chemicals announced it signed a co-marketing agreement of the osteoarthritis pain treatment ‘Cymbalta(generic name: Duloxetine Hcl)’ for patients that have adverse reactions to antidepressants and nons...
HUMIRA approved for non-infectious panuveitis treatment
On the 15th, Abbvie Korea(CEO Hong-Ki Yoo) and Eisai Korea(CEO Hong-Byung Ko) announced they acquired the Korean Ministry of Food and Drug Safety’s approval for the non-infectious intermediate, posterior and panuveiti...
Pharmacies’ fictitious demands aggravates burden of inventory for logistics companies
It was criticized a series of recent drug out-of-stock incidents have aggravated burden of inventory on pharmaceutical distribution companies.
According to the industry concerned, distribution companies are putting e...
Weakened profitability caused by high rate of cost to sales
It was criticized pharmaceutical companies’ profitability is getting weaker as the rate of cost to sales is increasing due to their increased sales of merchandise.
According to the Yakup Shinmoon’s(www.yakup.com) ana...
Next year’s health industry production, KRW 37 trillion, enlarged by 6.6%
The next year’s production in the healthcare industry is expected to increase by 6.6% to KRW 37 trillion. Considering the Korea’s expected GDP growth rate will be less than 3%, the healthcare industry will have a high...
